Research & products
We run to, not from, the world’s biggest health challenges.
The journey to invention and discovery is guided by science – and inspired by patients
Our purpose is to save and improve lives for generations. Our strategy is simple: We follow the science. The path to discovery is often unclear, but we are tireless in seeking solutions for some of the world’s most difficult health challenges.
Our work in numbers
people employed in research and development
people reached through our major programs and partnerships
invested in R&D in 2020
We address the world’s most difficult health challenges, following world-class science
Discovery & development
Our progress is due in large part to the important and tough scientific questions we set out to answer with our trials and collaborations. We are grateful to the thousands of volunteers who participate in our clinical trials – making this all possible.
Our commitment to patients is unwavering
As long as there are still patients in hospitals, doctors and nurses desperate to add years to the lives of their patients, and a world where treatments aren’t accessible to all, we will be here, fighting with all we have to deliver more, sooner.
Invention begins here
Our scientists are applying the latest groundbreaking research technologies and revolutionizing how we discover and develop medicines and vaccinesView our stories
Introducing our global hybrid working model
This model will help us be even more agile and productive as we deliver outcomes for the people who depend on our work.Read more
Understanding the link between social media and health
The Alliance for Advancing Health Online will look at social media’s role in health, starting with COVID-19 vaccine confidenceRead more
Harnessing tech to eliminate distance in a virtual world
An award-winning program has been key to our continued success despite limitations imposed by the COVID-19 pandemicRead more
Safeguarding the environment through green chemistry
When a manufacturing process doesn’t meet our standards, we build an award-winning, planet-friendly oneRead more
Our first-quarter 2021 financial results
Merck announced first-quarter sales of $12.1 billion, in-line with first-quarter 2020. Excluding the impact from foreign exchange, sales declined 1%. The company anticipates full-year 2021 revenue range to be between $51.8 billion and $53.8 billion, including a positive impact from foreign exchange of less than 2%. Take a look at the infographic below for more […]Read more